the lancet oncology

Rank: 17.79 /

Indexings	scopus ncbi
Short Name	lancet oncol
Abbreviated Name	lancet oncol
ISSN	1474-5488
Aim and Scope
URL
Author Instructions

Publications Per Year

Top 10 Most Clicked Articles

2017 Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U, ,

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study ,

18: -

Clicks: 362

2019 Giuliano, Mario, Schettini, Francesco, Rognoni, Carla, Milani, Manuela, Jerusalem, Guy, Bachelot, Thomas, De Laurentiis, Michelino, Thomas, Guglielmo, De Placido, Pietro, Arpino, Grazia, De Placido, Sabino, Cristofanilli, Massimo, Giordano, Antonio, Puglisi, Fabio, Pistilli, Barbara, Prat, Aleix, Del Mastro, Lucia, Venturini, Sergio, Generali, Daniele,

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. ,

Vol N/A: Pages N/A

Clicks: 260

2016 Dimopoulos, Meletios A, Moreau, Philippe, Palumbo, Antonio, Joshua, Douglas, Pour, Ludek, Hájek, Roman, Facon, Thierry, Ludwig, Heinz, Oriol, Albert, Goldschmidt, Hartmut, Rosiñol, Laura, Straub, Jan, Suvorov, Aleksandr, Araujo, Carla, Rimashevskaya, Elena, Pika, Tomas, Gaidano, Gianluca, Weisel, Katja, Goranova-Marinova, Vesselina, Schwarer, Anthony, Minuk, Leonard, Masszi, Tamás, Karamanesht, Ievgenii, Offidani, Massimo, Hungria, Vania, Spencer, Andrew, Orlowski, Robert Z, Gillenwater, Heidi H, Mohamed, Nehal, Feng, Shibao, Chng, Wee-Joo, , ,

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study. ,

17: 27-38

Clicks: 258

2016 Neal, Joel W, Dahlberg, Suzanne E, Wakelee, Heather A, Aisner, Seena C, Bowden, Michaela, Huang, Ying, Carbone, David P, Gerstner, Gregory J, Lerner, Rachel E, Rubin, Jerome L, Owonikoko, Taofeek K, Stella, Philip J, Steen, Preston D, Khalid, Ahmed Ali, Ramalingam, Suresh S, , ,

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. ,

17: 1661-1671

Clicks: 232

2020 Armstrong, Terri S, Dirven, Linda, Arons, David, Bates, Amanda, Chang, Susan M, Coens, Corneel, Espinasse, Claire, Gilbert, Mark R, Jenkinson, David, Kluetz, Paul, Mendoza, Tito, Rubinstein, Larry, Sul, Joohee, Weller, Michael, Wen, Patrick Y, van den Bent, Martin J, Taphoorn, Martin J B,

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. ,

21: e97-e103

Clicks: 231

2020 Herrmann, Ken, Schwaiger, Markus, Lewis, Jason S, Solomon, Stephen B, McNeil, Barbara J, Baumann, Michael, Gambhir, Sanjiv S, Hricak, Hedvig, Weissleder, Ralph,